{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T17:42:40Z","timestamp":1790962960363,"version":"4.1.0"},"reference-count":55,"publisher":"Springer Science and Business Media LLC","issue":"1","funder":[{"DOI":"10.13039\/501100003792","name":"Hj\u00e4rnfonden","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003792","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100006075","name":"Greta och Johan Kock Stiftelse","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100006075","id-type":"DOI","asserted-by":"publisher"}]},{"name":"SUS Stiftelser och donationer"},{"DOI":"10.13039\/100010815","name":"Stiftelsen f\u00f6r Gamla Tj\u00e4narinnor","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100010815","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Alz Res Therapy"],"published-print":{"date-parts":[[2017,12]]},"DOI":"10.1186\/s13195-017-0294-2","type":"journal-article","created":{"date-parts":[[2017,8,31]],"date-time":"2017-08-31T06:17:03Z","timestamp":1504160223000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":116,"title":["Early- versus late-onset Alzheimer\u2019s disease in clinical practice: cognitive and global outcomes over 3\u00a0years"],"prefix":"10.1186","volume":"9","author":[{"given":"Carina","family":"Wattmo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"\u00c5sa K.","family":"Wallin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2017,8,31]]},"reference":[{"key":"294_CR1","doi-asserted-by":"crossref","first-page":"782","DOI":"10.1111\/j.1468-1331.2005.01072.x","volume":"12","author":"O Yokota","year":"2005","unstructured":"Yokota O, Sasaki K, Fujisawa Y, Takahashi J, Terada S, Ishihara T, et al. Frequency of early and late-onset dementias in a Japanese memory disorders clinic. Eur J Neurol. 2005;12:782\u201390.","journal-title":"Eur J Neurol."},{"key":"294_CR2","doi-asserted-by":"crossref","first-page":"411","DOI":"10.3233\/JAD-132273","volume":"41","author":"H Eriksson","year":"2014","unstructured":"Eriksson H, Fereshtehnejad SM, Falahati F, Farahmand B, Religa D, Eriksdotter M. Differences in routine clinical practice between early and late onset Alzheimer\u2019s disease: data from the Swedish Dementia Registry (SveDem). J Alzheimers Dis. 2014;41:411\u20139.","journal-title":"J Alzheimers Dis."},{"key":"294_CR3","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.1111\/ene.12453","volume":"21","author":"PK Panegyres","year":"2014","unstructured":"Panegyres PK, Chen HY, Coalition against Major Diseases (CAMD). Early-onset Alzheimer\u2019s disease: a global cross-sectional analysis. Eur J Neurol. 2014;21:1149\u201354.","journal-title":"Eur J Neurol"},{"key":"294_CR4","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1046\/j.1365-2990.2002.00385.x","volume":"28","author":"EH Bigio","year":"2002","unstructured":"Bigio EH, Hynan LS, Sontag E, Satumtira S, White CL. Synapse loss is greater in presenile than senile onset Alzheimer disease: implications for the cognitive reserve hypothesis. Neuropathol Appl Neurobiol. 2002;28:218\u201327.","journal-title":"Neuropathol Appl Neurobiol."},{"key":"294_CR5","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1136\/bmj.288.6422.961","volume":"288","author":"MN Rossor","year":"1984","unstructured":"Rossor MN, Iversen LL, Reynolds GP, Mountjoy CQ, Roth M. Neurochemical characteristics of early and late onset types of Alzheimer\u2019s disease. Br Med J (Clin Res Ed). 1984;288:961\u20134.","journal-title":"Br Med J (Clin Res Ed)"},{"key":"294_CR6","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1212\/WNL.46.1.136","volume":"46","author":"E Koss","year":"1996","unstructured":"Koss E, Edland S, Fillenbaum G, Mohs R, Clark C, Galasko D, et al. Clinical and neuropsychological differences between patients with earlier and later onset of Alzheimer\u2019s disease: a CERAD analysis, part XII. Neurology. 1996;46:136\u201341.","journal-title":"Neurology."},{"key":"294_CR7","doi-asserted-by":"crossref","first-page":"1720","DOI":"10.1212\/WNL.0b013e31821a44dd","volume":"76","author":"M Balasa","year":"2011","unstructured":"Balasa M, Gelpi E, Antonell A, Rey MJ, Sanchez-Valle R, Molinuevo JL, et al. Clinical features and APOE genotype of pathologically proven early-onset Alzheimer disease. Neurology. 2011;76:1720\u20135.","journal-title":"Neurology."},{"key":"294_CR8","doi-asserted-by":"crossref","first-page":"1909","DOI":"10.1212\/01.WNL.0000069923.64550.9F","volume":"60","author":"DA Bennett","year":"2003","unstructured":"Bennett DA, Wilson RS, Schneider JA, Evans DA, de Leon CFM, Arnold SE, et al. Education modifies the relation of AD pathology to level of cognitive function in older persons. Neurology. 2003;60:1909\u201315.","journal-title":"Neurology."},{"key":"294_CR9","volume":"1","author":"J Birks","year":"2006","unstructured":"Birks J. Cholinesterase inhibitors for Alzheimer\u2019s disease. Cochrane Database Syst Rev. 2006;1, CD005593.","journal-title":"Cochrane Database Syst Rev."},{"key":"294_CR10","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1159\/000091790","volume":"21","author":"B Winblad","year":"2006","unstructured":"Winblad B, Wimo A, Engedal K, Soininen H, Verhey F, Waldemar G, et al. 3-year study of donepezil therapy in Alzheimer\u2019s disease: effects of early and continuous therapy. Dement Geriatr Cogn Disord. 2006;21:353\u201363.","journal-title":"Dement Geriatr Cogn Disord."},{"key":"294_CR11","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1001\/archneur.61.2.252","volume":"61","author":"MA Raskind","year":"2004","unstructured":"Raskind MA, Peskind ER, Truyen L, Kershaw P, Damaraju CV. The cognitive benefits of galantamine are sustained for at least 36\u00a0months: a long-term extension trial. Arch Neurol. 2004;61:252\u20136.","journal-title":"Arch Neurol."},{"key":"294_CR12","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1159\/000098052","volume":"23","author":"AK Wallin","year":"2007","unstructured":"Wallin AK, Andreasen N, Eriksson S, Batsman S, Nasman B, Ekdahl A, et al. Donepezil in Alzheimer\u2019s disease: what to expect after 3\u00a0years of treatment in a routine clinical setting. Dement Geriatr Cogn Disord. 2007;23:150\u201360.","journal-title":"Dement Geriatr Cogn Disord."},{"key":"294_CR13","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1186\/alzrt85","volume":"3","author":"C Wattmo","year":"2011","unstructured":"Wattmo C, Wallin AK, Londos E, Minthon L. Predictors of long-term cognitive outcome in Alzheimer\u2019s disease. Alzheimers Res Ther. 2011;3:23.","journal-title":"Alzheimers Res Ther."},{"key":"294_CR14","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.jalz.2009.05.665","volume":"6","author":"K Ito","year":"2010","unstructured":"Ito K, Ahadieh S, Corrigan B, French J, Fullerton T, Tensfeldt T. Disease progression meta-analysis model in Alzheimer\u2019s disease. Alzheimers Dement. 2010;6:39\u201353.","journal-title":"Alzheimers Dement."},{"key":"294_CR15","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1002\/(SICI)1099-1166(200001)15:1<50::AID-GPS75>3.0.CO;2-M","volume":"15","author":"M Evans","year":"2000","unstructured":"Evans M, Ellis A, Watson D, Chowdhury T. Sustained cognitive improvement following treatment of Alzheimer\u2019s disease with donepezil. Int J Geriatr Psychiatry. 2000;15:50\u20133.","journal-title":"Int J Geriatr Psychiatry."},{"key":"294_CR16","doi-asserted-by":"crossref","first-page":"1421","DOI":"10.1002\/(SICI)1097-0258(20000615\/30)19:11\/12<1421::AID-SIM434>3.0.CO;2-P","volume":"19","author":"DR Galasko","year":"2000","unstructured":"Galasko DR, Gould RL, Abramson IS, Salmon DP. Measuring cognitive change in a cohort of patients with Alzheimer\u2019s disease. Stat Med. 2000;19:1421\u201332.","journal-title":"Stat Med."},{"key":"294_CR17","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1006\/brcg.1996.0038","volume":"31","author":"DX Rasmusson","year":"1996","unstructured":"Rasmusson DX, Carson KA, Brookmeyer R, Kawas C, Brandt J. Predicting rate of cognitive decline in probable Alzheimer\u2019s disease. Brain Cogn. 1996;31:133\u201347.","journal-title":"Brain Cogn."},{"key":"294_CR18","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/0165-1781(92)90074-D","volume":"42","author":"RG Stern","year":"1992","unstructured":"Stern RG, Mohs RC, Bierer LM, Silverman JM, Schmeidler J, Davidson M, et al. Deterioration on the Blessed test in Alzheimer\u2019s disease: longitudinal data and their implications for clinical trials and identification of subtypes. Psychiatry Res. 1992;42:101\u201310.","journal-title":"Psychiatry Res."},{"key":"294_CR19","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1111\/j.1532-5415.1991.tb05904.x","volume":"39","author":"A Burns","year":"1991","unstructured":"Burns A, Jacoby R, Levy R. Progression of cognitive impairment in Alzheimer\u2019s disease. J Am Geriatr Soc. 1991;39:39\u201345.","journal-title":"J Am Geriatr Soc."},{"key":"294_CR20","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1111\/j.1532-5415.1987.tb01315.x","volume":"35","author":"FJ Huff","year":"1987","unstructured":"Huff FJ, Growdon JH, Corkin S, Rosen TJ. Age at onset and rate of progression of Alzheimer\u2019s disease. J Am Geriatr Soc. 1987;35:27\u201330.","journal-title":"J Am Geriatr Soc."},{"key":"294_CR21","doi-asserted-by":"crossref","first-page":"1945","DOI":"10.1017\/S1041610214001173","volume":"26","author":"K Stanley","year":"2014","unstructured":"Stanley K, Walker Z. Do patients with young onset Alzheimer\u2019s disease deteriorate faster than those with late onset Alzheimer\u2019s disease? A review of the literature. Int Psychogeriatr. 2014;26:1945\u201353.","journal-title":"Int Psychogeriatr."},{"key":"294_CR22","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1097\/WAD.0b013e3181f5dd97","volume":"25","author":"C Wattmo","year":"2011","unstructured":"Wattmo C, Wallin AK, Londos E, Minthon L. Long-term outcome and prediction models of activities of daily living in Alzheimer disease with cholinesterase inhibitor treatment. Alzheimer Dis Assoc Disord. 2011;25:63\u201372.","journal-title":"Alzheimer Dis Assoc Disord."},{"key":"294_CR23","doi-asserted-by":"crossref","first-page":"565","DOI":"10.2147\/NDT.S24196","volume":"7","author":"AK Wallin","year":"2011","unstructured":"Wallin AK, Wattmo C, Minthon L. Galantamine treatment in Alzheimer\u2019s disease: response and long-term outcome in a routine clinical setting. Neuropsychiatr Dis Treat. 2011;7:565\u201376.","journal-title":"Neuropsychiatr Dis Treat."},{"key":"294_CR24","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1159\/000455943","volume":"7","author":"C Wattmo","year":"2017","unstructured":"Wattmo C, Wallin AK. Early- versus late-onset Alzheimer disease: long-term functional outcomes, nursing home placement, and risk factors for rate of progression. Dement Geriatr Cogn Disord Extra. 2017;7:172\u201387.","journal-title":"Dement Geriatr Cogn Disord Extra."},{"key":"294_CR25","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/0022-3956(75)90026-6","volume":"12","author":"MF Folstein","year":"1975","unstructured":"Folstein MF, Folstein SE, McHugh PR. \u201cMini-mental state\u201d: a practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res. 1975;12:189\u201398.","journal-title":"J Psychiatr Res."},{"key":"294_CR26","volume-title":"Diagnostic and statistical manual of mental disorders","author":"American Psychiatric Association","year":"1994","unstructured":"American Psychiatric Association. Diagnostic and statistical manual of mental disorders. 4th ed. Washington, DC: American Psychiatric Association; 1994.","edition":"4"},{"key":"294_CR27","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1212\/WNL.34.7.939","volume":"34","author":"G McKhann","year":"1984","unstructured":"McKhann G, Drachman D, Folstein M, Katzman R, Price D, Stadlan EM. Clinical diagnosis of Alzheimer\u2019s disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer\u2019s Disease. Neurology. 1984;34:939\u201344.","journal-title":"Neurology."},{"key":"294_CR28","doi-asserted-by":"crossref","first-page":"1356","DOI":"10.1176\/ajp.141.11.1356","volume":"141","author":"WG Rosen","year":"1984","unstructured":"Rosen WG, Mohs RC, Davis KL. A new rating scale for Alzheimer\u2019s disease. Am J Psychiatry. 1984;141:1356\u201364.","journal-title":"Am J Psychiatry."},{"key":"294_CR29","doi-asserted-by":"crossref","first-page":"2315","DOI":"10.1212\/WNL.44.12.2315","volume":"44","author":"DS Knopman","year":"1994","unstructured":"Knopman DS, Knapp MJ, Gracon SI, Davis CS. The Clinician Interview-Based Impression (CIBI): a clinician\u2019s global change rating scale in Alzheimer\u2019s disease. Neurology. 1994;44:2315\u201321.","journal-title":"Neurology."},{"key":"294_CR30","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1093\/geront\/9.3_Part_1.179","volume":"9","author":"MP Lawton","year":"1969","unstructured":"Lawton MP, Brody EM. Assessment of older people: self-maintaining and instrumental activities of daily living. Gerontologist. 1969;9:179\u201386.","journal-title":"Gerontologist."},{"key":"294_CR31","doi-asserted-by":"crossref","first-page":"963","DOI":"10.2307\/2529876","volume":"38","author":"NM Laird","year":"1982","unstructured":"Laird NM, Ware JH. Random-effects models for longitudinal data. Biometrics. 1982;38:963\u201374.","journal-title":"Biometrics."},{"key":"294_CR32","doi-asserted-by":"crossref","first-page":"501","DOI":"10.7326\/0003-4819-140-7-200404060-00008","volume":"140","author":"EB Larson","year":"2004","unstructured":"Larson EB, Shadlen MF, Wang L, McCormick WC, Bowen JD, Teri L, et al. Survival after initial diagnosis of Alzheimer disease. Ann Intern Med. 2004;140:501\u20139.","journal-title":"Ann Intern Med."},{"key":"294_CR33","doi-asserted-by":"crossref","first-page":"40","DOI":"10.4236\/aad.2013.21005","volume":"2","author":"G Spalletta","year":"2013","unstructured":"Spalletta G, De Luca V, Padovani A, Rozzini L, Perri R, Bruni A, et al. Early onset versus late onset in Alzheimer\u2019s disease: what is the reliable cut-off? Adv Alzheimer Dis. 2013;2:40\u20137.","journal-title":"Adv Alzheimer Dis."},{"key":"294_CR34","doi-asserted-by":"crossref","first-page":"1907","DOI":"10.1017\/S0033291709005492","volume":"39","author":"AE Vlies van der","year":"2009","unstructured":"van der Vlies AE, Koedam EL, Pijnenburg YA, Twisk JW, Scheltens P, van der Flier WM. Most rapid cognitive decline in APOE\u03b54 negative Alzheimer\u2019s disease with early onset. Psychol Med. 2009;39:1907\u201311.","journal-title":"Psychol Med."},{"key":"294_CR35","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1212\/WNL.0000000000001376","volume":"84","author":"LS Schneider","year":"2015","unstructured":"Schneider LS, Kennedy RE, Wang G, Cutter GR. Differences in Alzheimer disease clinical trial outcomes based on age of the participants. Neurology. 2015;84:1121\u20137.","journal-title":"Neurology."},{"key":"294_CR36","first-page":"458","volume":"24","author":"E Kramer-Ginsberg","year":"1988","unstructured":"Kramer-Ginsberg E, Mohs RC, Aryan M, Lobel D, Silverman J, Davidson M, et al. Clinical predictors of course for Alzheimer patients in a longitudinal study: a preliminary report. Psychopharmacol Bull. 1988;24:458\u201362.","journal-title":"Psychopharmacol Bull."},{"key":"294_CR37","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1159\/000337386","volume":"33","author":"H Gronning","year":"2012","unstructured":"Gronning H, Rahmani A, Gyllenborg J, Dessau RB, Hogh P. Does Alzheimer\u2019s disease with early onset progress faster than with late onset? A case-control study of clinical progression and cerebrospinal fluid biomarkers. Dement Geriatr Cogn Disord. 2012;33:111\u20137.","journal-title":"Dement Geriatr Cogn Disord."},{"key":"294_CR38","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1186\/alzrt25","volume":"2","author":"RS Doody","year":"2010","unstructured":"Doody RS, Pavlik V, Massman P, Rountree S, Darby E, Chan W. Predicting progression of Alzheimer\u2019s disease. Alzheimers Res Ther. 2010;2:2.","journal-title":"Alzheimers Res Ther."},{"key":"294_CR39","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1017\/S1041610209991001","volume":"22","author":"PA Wilkosz","year":"2010","unstructured":"Wilkosz PA, Seltman HJ, Devlin B, Weamer EA, Lopez OL, DeKosky ST, et al. Trajectories of cognitive decline in Alzheimer\u2019s disease. Int Psychogeriatr. 2010;22:281\u201390.","journal-title":"Int Psychogeriatr."},{"key":"294_CR40","doi-asserted-by":"crossref","first-page":"1607","DOI":"10.1002\/(SICI)1097-0258(20000615\/30)19:11\/12<1607::AID-SIM449>3.0.CO;2-O","volume":"19","author":"MS Mendiondo","year":"2000","unstructured":"Mendiondo MS, Ashford JW, Kryscio RJ, Schmitt FA. Modelling Mini Mental State Examination changes in Alzheimer\u2019s disease. Stat Med. 2000;19:1607\u201316.","journal-title":"Stat Med."},{"key":"294_CR41","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1002\/(SICI)1099-1166(199809)13:9<625::AID-GPS835>3.0.CO;2-2","volume":"13","author":"SH MacGowan","year":"1998","unstructured":"MacGowan SH, Wilcock GK, Scott M. Effect of gender and apolipoprotein E genotype on response to anticholinesterase therapy in Alzheimer\u2019s disease. Int J Geriatr Psychiatry. 1998;13:625\u201330.","journal-title":"Int J Geriatr Psychiatry."},{"key":"294_CR42","doi-asserted-by":"crossref","first-page":"215","DOI":"10.2174\/1567205013666151218145752","volume":"13","author":"J Xu","year":"2016","unstructured":"Xu J, Xia LL, Song N, Chen SD, Wang G. Testosterone, estradiol, and sex hormone-binding globulin in Alzheimer\u2019s disease: a meta-analysis. Curr Alzheimer Res. 2016;13:215\u201322.","journal-title":"Curr Alzheimer Res."},{"key":"294_CR43","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1016\/S0197-4580(03)00118-0","volume":"25","author":"N Raz","year":"2004","unstructured":"Raz N, Gunning-Dixon F, Head D, Rodrigue KM, Williamson A, Acker JD. Aging, sexual dimorphism, and hemispheric asymmetry of the cerebral cortex: replicability of regional differences in volume. Neurobiol Aging. 2004;25:377\u201396.","journal-title":"Neurobiol Aging."},{"key":"294_CR44","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1001\/archpsyc.62.6.685","volume":"62","author":"LL Barnes","year":"2005","unstructured":"Barnes LL, Wilson RS, Bienias JL, Schneider JA, Evans DA, Bennett DA. Sex differences in the clinical manifestations of Alzheimer disease pathology. Arch Gen Psychiatry. 2005;62:685\u201391.","journal-title":"Arch Gen Psychiatry."},{"key":"294_CR45","doi-asserted-by":"crossref","first-page":"1942","DOI":"10.1212\/WNL.53.9.1942","volume":"53","author":"Y Stern","year":"1999","unstructured":"Stern Y, Albert S, Tang MX, Tsai WY. Rate of memory decline in AD is related to education and occupation: cognitive reserve? Neurology. 1999;53:1942\u20137.","journal-title":"Neurology."},{"key":"294_CR46","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1159\/000093316","volume":"22","author":"T Kleiman","year":"2006","unstructured":"Kleiman T, Zdanys K, Black B, Rightmer T, Grey M, Garman K, et al. Apolipoprotein E \u03b54 allele is unrelated to cognitive or functional decline in Alzheimer\u2019s disease: retrospective and prospective analysis. Dement Geriatr Cogn Disord. 2006;22:73\u201382.","journal-title":"Dement Geriatr Cogn Disord."},{"key":"294_CR47","doi-asserted-by":"crossref","first-page":"1888","DOI":"10.1212\/01.wnl.0000188871.74093.12","volume":"65","author":"CA Martins","year":"2005","unstructured":"Martins CA, Oulhaj A, de Jager CA, Williams JH. APOE alleles predict the rate of cognitive decline in Alzheimer disease: a nonlinear model. Neurology. 2005;65:1888\u201393.","journal-title":"Neurology."},{"key":"294_CR48","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1017\/S0317167100013949","volume":"39","author":"L Wu","year":"2012","unstructured":"Wu L, Rosa-Neto P, Hsiung GY, Sadovnick AD, Masellis M, Black SE, et al. Early-onset familial Alzheimer\u2019s disease (EOFAD). Can J Neurol Sci. 2012;39:436\u201345.","journal-title":"Can J Neurol Sci."},{"key":"294_CR49","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1192\/bjp.167.4.537","volume":"167","author":"C Ballard","year":"1995","unstructured":"Ballard C, Bannister C, Graham C, Oyebode F, Wilcock G. Associations of psychotic symptoms in dementia sufferers. Br J Psychiatry. 1995;167:537\u201340.","journal-title":"Br J Psychiatry."},{"key":"294_CR50","doi-asserted-by":"crossref","first-page":"2022","DOI":"10.1176\/appi.ajp.162.11.2022","volume":"162","author":"SA Ropacki","year":"2005","unstructured":"Ropacki SA, Jeste DV. Epidemiology of and risk factors for psychosis of Alzheimer\u2019s disease: a review of 55 studies published from 1990 to 2003. Am J Psychiatry. 2005;162:2022\u201330.","journal-title":"Am J Psychiatry."},{"key":"294_CR51","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1176\/appi.ajp.2011.08121844","volume":"168","author":"CL Vigen","year":"2011","unstructured":"Vigen CL, Mack WJ, Keefe RS, Sano M, Sultzer DL, Stroup TS, et al. Cognitive effects of atypical antipsychotic medications in patients with Alzheimer\u2019s disease: outcomes from CATIE-AD. Am J Psychiatry. 2011;168:831\u20139.","journal-title":"Am J Psychiatry."},{"key":"294_CR52","doi-asserted-by":"crossref","first-page":"1451","DOI":"10.1212\/WNL.45.8.1451","volume":"45","author":"D Galasko","year":"1995","unstructured":"Galasko D, Edland SD, Morris JC, Clark C, Mohs R, Koss E. The Consortium to Establish a Registry for Alzheimer\u2019s Disease (CERAD). Part XI. Clinical milestones in patients with Alzheimer\u2019s disease followed over 3 years. Neurology. 1995;45:1451\u20135.","journal-title":"Neurology"},{"key":"294_CR53","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1002\/gps.2534","volume":"26","author":"G Alva","year":"2011","unstructured":"Alva G, Grossberg GT, Schmitt FA, Meng X, Olin JT. Efficacy of rivastigmine transdermal patch on activities of daily living: item responder analyses. Int J Geriatr Psychiatry. 2011;26:356\u201363.","journal-title":"Int J Geriatr Psychiatry."},{"key":"294_CR54","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1097\/00019442-200407000-00003","volume":"12","author":"CW Ritchie","year":"2004","unstructured":"Ritchie CW, Ames D, Clayton T, Lai R. Metaanalysis of randomized trials of the efficacy and safety of donepezil, galantamine, and rivastigmine for the treatment of Alzheimer disease. Am J Geriatr Psychiatry. 2004;12:358\u201369.","journal-title":"Am J Geriatr Psychiatry."},{"key":"294_CR55","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1111\/j.1600-0404.1993.tb05356.x","volume":"88","author":"M Haupt","year":"1993","unstructured":"Haupt M, Pollmann S, Kurz A. Symptom progression in Alzheimer\u2019s disease: relation to onset age and familial aggregation. Results of a longitudinal study. Acta Neurol Scand. 1993;88:349\u201353.","journal-title":"Acta Neurol Scand"}],"container-title":["Alzheimer's Research &amp; Therapy"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13195-017-0294-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,10,2]],"date-time":"2019-10-02T20:11:37Z","timestamp":1570047097000},"score":1,"resource":{"primary":{"URL":"http:\/\/alzres.biomedcentral.com\/articles\/10.1186\/s13195-017-0294-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,8,31]]},"references-count":55,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2017,12]]}},"alternative-id":["294"],"URL":"https:\/\/doi.org\/10.1186\/s13195-017-0294-2","relation":{},"ISSN":["1758-9193"],"issn-type":[{"value":"1758-9193","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,8,31]]},"article-number":"70"}}